NFKB1 and glioblastoma: Our next goal was to analyze the impact of the studied nanoformulations on the NF-κB pathway, a crucial signaling pathway frequently activated in GBM cells and implicated in various aspects of tumor development, including the maintenance of glioma stem cells, invasion, and resistance to treatment.